NASDAQ
ICU
Last Price
US $4.80
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
SeaStar Medical Holding Corporation cash flow to debt ratio of -2.59K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
SeaStar Medical Holding Corporation's free cash flow has increased -15.04% from $-16.01M last year to $-13.60M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
SeaStar Medical Holding Corporation's debt to equity ratio is 0.05, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
SeaStar Medical Holding Corporation's debt has increased relative to shareholder equity from -0.26 last year to 0.05 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
SeaStar Medical Holding Corporation has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
SeaStar Medical Holding Corporation's interest coverage ratio is -36.67, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
SeaStar Medical Holding Corporation's profit margin has increased (-95.49%) in the last year from -18.39K% to -828.62%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
SeaStar Medical Holding Corporation's short-term assets of $13.58M exceed its short-term liabilities of $3.74M
Decreasing performance - ROA.
SeaStar Medical Holding Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
SeaStar Medical Holding Corporation's return on equity of -146.29%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
SeaStar Medical Holding Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
SeaStar Medical Holding Corporation had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
SeaStar Medical Holding Corporation has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
SeaStar Medical Holding Corporation has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
SeaStar Medical Holding Corporation's yearly earnings has increased -51.07% since last year from $-24.83M to $-12.15M, signaling increasing performance
Increasing performance - Healthy revenue growth.
SeaStar Medical Holding Corporation's yearly revenue has increased 814.07% since last year from $135.00K to $1.23M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -156.34% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
SeaStar Medical Holding Corporation has insufficient revenue history to calculate 3-year revenue CAGR.
Increasing performance - Revenue consistency.
SeaStar Medical Holding Corporation had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
SeaStar Medical Holding Corporation had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
SeaStar Medical Holding Corporation has insufficient data to evaluate this check.
Overvalued - Earnings yield.
SeaStar Medical Holding Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
SeaStar Medical Holding Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
SeaStar Medical Holding Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
SeaStar Medical Holding Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
SeaStar Medical Holding Corporation has a price-to-book ratio of 25.71x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Overvalued - P/S ratio.
SeaStar Medical Holding Corporation has a price-to-sales ratio of 131.15x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-146.29%
Return on equity
ROIC: -156.34%
Valuation History
-1.2X
Price to Earnings
EV/EBITDA: -0.42X
Cash flow
Profit margin
0.00%
(FY vs FY)
Cash flow Y/Y
-16.34%
(FY vs FY)
Fair Value
Market $4.80
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.